ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ABDX Abingdon Health Plc

11.00
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Abingdon Health Plc LSE:ABDX London Ordinary Share GB00BLF79J41 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.00 10.50 11.50 11.00 11.00 11.00 75,352 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.05M -3.45M -0.0284 -3.87 13.39M
Abingdon Health Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker ABDX. The last closing price for Abingdon Health was 11p. Over the last year, Abingdon Health shares have traded in a share price range of 6.75p to 18.00p.

Abingdon Health currently has 121,716,822 shares in issue. The market capitalisation of Abingdon Health is £13.39 million. Abingdon Health has a price to earnings ratio (PE ratio) of -3.87.

Abingdon Health Share Discussion Threads

Showing 1626 to 1650 of 1650 messages
Chat Pages: 66  65  64  63  62  61  60  59  58  57  56  55  Older
DateSubjectAuthorDiscuss
17/5/2024
13:23
CEO speaking to Proactive after the interim results:
z1co
17/5/2024
13:20
Proactive Investors:

Abingdon Health CEO discusses strong interim results, robust pipeline and growth strategy

Published: 10:38 15 Mar 2024 GMT

Yates said a 117% revenue increase to £2.4 million during the interim period was primarily driven by its CDMO division. This growth was attributed to increases in development, operational revenues, and the emergence of regulatory area revenues.

Despite an inflationary environment, Abingdon Health managed to maintain stable operating costs, resulting in improved gross margins to over 50%.

The company has a robust opportunity pipeline with 29 ongoing projects, emphasizing its fully integrated solution's appeal to customers. Yates also highlighted a good start to the second half of the year, with revenues expected to grow significantly while controlling costs to enhance operating profit performance.

z1co
17/5/2024
12:59
York, U.K. 15th May 2024: Abingdon Health plc (AIM: ABDX), a leading international lateral flow Contract Development and Manufacturing Organisation (CDMO), announces the launch of Boots own-brand, saliva pregnancy self-test across the UK and online, in partnership with Salignostics and Crest Medical.


On 20th March 2024, Abingdon Health announced the launch of the first two Boots branded self-tests - Iron and Vitamin D deficiency - in-store and online at boots.com.


In another step toward strengthening this partnership with Boots, Abingdon Health is now pleased to announce the launch of the first ever saliva pregnancy test under the Boots own brand range. The test is being made available in store and online at boots.com from Spring 2024 onwards. This product launch allows more people to access a new way of testing for pregnancy.


With the UK pregnancy self-test market expected to reach USD $56.7 million by 20331, this provides a strategic opportunity to launch, on an own-brand basis, an innovative product in this growing market with the UK's leading health and beauty retailer. With general consumer adoption of self-tests on the rise (US $7.89 billion in 2023)2, and a robust pipeline of products within its CRO/CDMO offering, Abingdon Health is well positioned to continue developing OEM retail relationships within the UK and Europe as a value-add, innovative Private Label Supplier (PLS).

z1co
17/5/2024
12:57
!FOLLOWFEED
Launch of the Saliva Pregnancy self-test in Boots

Boots will be the first retailer to sell the world's first saliva pregnancy self-test under its own brand label

Tests will be available in Boots stores and online across the UK provided by Abingdon Health, Salignostics and Crest Medical partnership

z1co
20/3/2024
08:18
And were by chance called Bobdown1 before?.
highrisk1
20/3/2024
08:17
What's nice about it?, Bob.
highrisk1
20/3/2024
07:08
Nice to see abindon recovering from the tory debacle. Nice rns.
bobdown2
15/3/2024
15:26
Timbo

I thought the outlook statement was very misleading. Last year ABDX had a strong H2 weighting and it looks to be the same this year, so to say H2 will be materially ahead of H1 is meaningless. A comparison with H2 last year would have given investors a much better insight. Growth will not be 116% in H2 but I want to know
1. Will it be positive and
2. If positive, by roughly how much 20/30/40% etc.
Also, the cash outflow in H1 was £1.238m and they only have £2m cash left. While the burn rate will be lower in H2, without better guidance, it becomes impossible for private investors to make an informed view on the H2 outflow. No doubt Brokers will have been greater insight but it's not much help to me.
Based on the lack of clarity, I can't dismiss the need for another fund raise.

daz
14/3/2024
12:39
Timbo,

I’ll join you tomorrow

dennisbergkamp
14/3/2024
11:30
How times change!

* Confirmation today that no additional funding required
* Robust current trading
* top of the leader board today
* Last (very substantial) director purchases (at the last placing) were at level 2.5 X the current share price

and no comments?

timbo003
14/3/2024
08:22
Note "without the need for additional funding"
timbo003
14/3/2024
08:21
From today's statement:
timbo003
17/1/2024
09:40
Recording from the Proactive event last week now available:
timbo003
23/12/2023
12:35
A date for your diaries and a chance to meet the company management if you in or around the London area on January 11th:
timbo003
16/10/2023
11:44
Switched to APH
blackhorse23
14/10/2023
14:42
Register for the seminar mentioned in the previous post (which includes a presentation from ABDX) here:
timbo003
14/10/2023
11:45
ShareSoc is holding its first hybrid event in London on 19th Oct. Hear from Abingdon Health (ABDX) and other healthcare companies like Tristel Plc (TSTL), Inspiration Healthcare Group (IHC), Creo Medical Group (CREO) and GENincode (GENI). Attend in-person or online.📍 7760; Register: [...]
sharesoc
16/8/2023
14:06
Looks that way....
SalistickTM is the first rapid saliva-based pregnancy test with a new and improved user-experience, and high accuracy for early pregnancy detection. The kit is based on our revolutionary technology which detects the pregnancy hormone β-hCG in saliva.

greenfingerz
16/8/2023
12:27
Is this the only one uk or global like it?
awise355
16/8/2023
12:09
SaliStick test kit, received the CE mark from the European authorities and is currently working towards receiving FDA approval in the U.S.Saliva-based pregnancy test: 'Self-Testing Anywhere, by Anyone'"With SaliStick, a pregnancy test can be done anywhere and at any convenient time", says Salignostics."Saliva is the key to rapid diagnostics for a variety of medical reasons. It is the only non-invasive, easy, and hygienic means to detect hormones, viruses, and even diseases," adds Prof. Aaron Palmon, co-founder of Salignostics.This product completely removes the need for blood and urine samples when testing for pregnancy"With SaliStick, we leverage the powerful diagnostics abilities we have been able to create from analyzing saliva. This product completely removes the need for blood and urine samples when testing for pregnancy."Salignostics claims that the process is straightforward, easy to use and provides accurate results within a few minutes. It also boasts that the test can be done more conveniently and without needing a bathroom.
smackeraim
15/8/2023
12:55
Well certainly enjoyed reading back some of the trolls posts today.Guess they've retreated to their caves....Aw bless!
saint in exile
12/7/2023
11:43
Added to holding at this level.
red army
29/6/2023
07:23
Caveat emptor
volsung
28/6/2023
22:53
Had to pay my road tax today. Long story short. So ventured into a smaller Superdrug outlet. No Salistick on display. The representative said that she knew of them and they were being supplied to the larger shops first and the smaller ones later. A recent delivery was awaiting shop distribution of latest delivery ...are we there?...
That's a distribution factor I suppose.
Anyways. Ongoing.
Spit or pee? That is the question!
And the price point is well within the parameters of the markets. One of the clear blue 29.99.
Check it out for yourself.
Even if you identify as a potato you can check out if you are impregnated by a mouth swab as opposed to a urinal splatter test.

criticalthinker1
23/6/2023
09:19
ouch! for the long termers

luckilly i am just a trader and exited a 12.5p buy with a 14p sell gl

purple11
Chat Pages: 66  65  64  63  62  61  60  59  58  57  56  55  Older

Your Recent History

Delayed Upgrade Clock